disease

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel…
Read More...

Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene…
Read More...

Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for…
Read More...

AstraZeneca's stock jumped as much as 4% after Britain's most valuable company said its experimental lung disease…
Read More...

Thomas Fuller | Nurphoto | Getty ImagesPfizer on Monday said it will seek regulatory approval for a Lyme disease…
Read More...

I've spent the last 25 years in front of the camera here at CNBC, and people have gotten to know a lot about me.What…
Read More...

Investor Insight Cardiol Therapeutics is positioned…
Read More...

“My income is $120,000 per year which includes $60,000 in Social Security and a pension.” Read More: I’m single,…
Read More...